No Carolina / NY / Florida
Ph: 561.316.3330

Joe Gabler Appointed Chief Growth Office at Paytient

Summation

  • “Paytient is improving healthcare with a strategy that puts choice and affordability in the hands of members, knowing they need to be at the heart of real change.
  • Paytient is well positioned to serve as the leading platform giving Americans a better ability to access and afford care,” said Brian Whorley, Founder and CEO of Paytient.
  • “As we prepare for the growth this will bring, Joe's proven ability to scale teams and operations with winning cultures is a fantastic and critical addition to our leadership team.

Paytient, the leading provider of health plan affordability solutions, announces today the addition of Joe Gabler as Chief Growth Officer. Joe Gabler is a senior executive and healthcare consumer payments pioneer with nearly 20 years of experience building companies around winning cultures. Joe will join Paytient to drive growth and expansion as the company continues to partner with leading employers, payers, and PBMs.

Serving over 5,000 enterprise partners with nearly 25 million lives moving into 2025, Paytient welcomes Joe to scale its partnerships with mid-market employers, large commercial groups, leading payers, and Medicare plan sponsors to make healthcare more easily accessible for millions more Americans in the coming years.

“The Medicare Prescription Payment Plan in 2025 means that smoothing out-of-pocket costs over time is becoming a standard of care for healthcare in the United States. Paytient is well positioned to serve as the leading platform giving Americans a better ability to access and afford care,” said Brian Whorley, Founder and CEO of Paytient. “As we prepare for the growth this will bring, Joe’s proven ability to scale teams and operations with winning cultures is a fantastic and critical addition to our leadership team.

Joe Gabler comments:

“Paytient is improving healthcare with a strategy that puts choice and affordability in the hands of members, knowing they need to be at the heart of real change. I’ve seen what can happen when people are empowered to care for their whole health, which is increasingly out of reach these days. I’m incredibly excited to join the amazing team at Paytient and passionately help expand the reach of this mission.”
Joe Gabler spent the first 13 years of his career helping SPS Commerce (SPSC) grow from a small business to a hugely successful IPO and multi-billion dollar market value. There he held multiple operations, strategy, and growth management positions. The next 6 years saw him reinventing the healthcare benefits landscape, leveraging innovative consumer payments strategies at Solutran, now acquired by Optum. They built a market-leading payment network serving over half the Medicare Advantage market and processing billions of dollars yearly in consumer benefit payments. Paytient is excited to welcome Joe onto its executive leadership team and leverage his expertise to pursue new growth opportunities.
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

- Advertisement -

spot_img

- Advertisement -

Franck Mevellec Appointed Senior Director, Business Development at Asymchem

Franck Mevellec boasts a proven track record of success, having held key positions at industry leaders like Bayer Healthcare (R&D), Teva Pharmaceuticals (portfolio director), Minakem (BD director), and most recently, Seqens (global head of sales). He joins Asymchem with a focus on expanding the company’s footprint across Europe.

Veristat Appoints Dr Gabriela Rosu to Lead Growing Medical Affairs Team

Dr Gabriela Rosu is a seasoned professional with over twenty years of experience in scientific and clinical fields, having significantly contributed to the planning and execution of pivotal activities that have led to the approval and commercialization of groundbreaking therapies.

Sphere Fluidics Appoints Curtis Nicholson as Director of Sales, EMEA, to Support Accelerated Growth in Key Markets

Curtis Nicholson said “I’m thrilled to leverage my experience in strategic sales and driving innovation to take on this exciting role at Sphere Fluidics. I look forward to collaborating with the talented team and accelerating the adoption of our transformative solutions.”

By using this website you agree to accept Medical Device News Magazine Privacy Policy